CRMD) have been struggling lately and have lost 7.7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with ...
today announces its preliminary unaudited fourth quarter results and provides an update on its business. These inc RBC Capital raised the firm’s price target on CorMedix (CRMD) to $12 from $11 ...